Life Sciences & Biotechnology
Pre-clinical evaluation of combination adjuvants for humoral & T cell immunity to respiratory Syncytial virus
Investigating SARS-CoV2 3-5 exonuclease (NSP14/ExoN) as therapeutic target for CoVID19
Inhibition of interaction between receptor binding domain of spike protein of SARS-CoV-2 & human ACE2 by protein mimic DNA [BT/TEMP10623/COVID/02/20]
Identifying therapeutic targets for blocking infection of highly pathogenic SARS-CoV-2 at an early stage- Developing novel screening assay with minimal bio-hazard risk
High-affinity binders against COVID-19 spike protein using display libraries
Heparinoids based adjuvants for flaviviruses vaccine development
DNA repair in giant viruses- Biochemical insights into the first virus-coded putative base excision repair pathway
Development of anti-viral peptide aptamers for SARS-Cov-2- Design & evaluation
Development of an endogenous STING agonist adjuvanted mycobacterium bovis BCG vaccine to enhance efficacy against tuberculosis
Design & synthesis of novel iminosugar variants & their cationic amphiphiles as antiviral therapeutics against Dengue Virus (DENV)
Pages
